Disease ID | Disease name | Source of annotation with RPS6KA3 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
303600 | COFFIN-LOWRY SYNDROME | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | RPS6KA3 |
PS309530 | MENTAL RETARDATION, NONSYNDROMIC, X-LINKED | ClinVar, OMIM, HUMSAVAR | link to OMIM | 25 | THOC2, HCFC1, RPS6KA3, USP9X, MID2, RAB39B, KIAA2022, ZNF81, PAK3, IQSEC2, DLG3, TSPAN7, ZDHHC15, ZNF711, KIF4A, ACSL4, BRWD3, IL1RAPL1, GDI1, SYP, ARHGEF6, ARX, DDX3X, GRIA3, FTSJ1 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Oocyte meiosis | hsa04114 | 5.91 |
Long-term potentiation | hsa04720 | 6.64 |
Neurotrophin signaling pathway | hsa04722 | 5.78 |
Progesterone-mediated oocyte maturation | hsa04914 | 6.18 |
MAPK signaling pathway | hsa04010 | 4.63 |
mTOR signaling pathway | hsa04150 | 6.72 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
Cellular Senescence | R-HSA-2559583 | 5.7 |
Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.77 |
Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
Immune System | R-HSA-168256 | 2.37 |
Recycling pathway of L1 | R-HSA-437239 | 7.62 |
Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
RSK activation | R-HSA-444257 | 10.4 |
Post NMDA receptor activation events | R-HSA-438064 | 7.85 |
ERK/MAPK targets | R-HSA-198753 | 8.59 |
CREB phosphorylation through the activation of Ras | R-HSA-442742 | 8.23 |
Developmental Biology | R-HSA-1266738 | 3.48 |
Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.08 |
Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
Cellular responses to stress | R-HSA-2262752 | 4.56 |
CREB phosphorylation | R-HSA-199920 | 10.18 |
Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.4 |
Neuronal System | R-HSA-112316 | 4.82 |
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | R-HSA-112314 | 5.85 |
Transmission across Chemical Synapses | R-HSA-112315 | 5.28 |
Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
L1CAM interactions | R-HSA-373760 | 6.19 |
Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
Innate Immune System | R-HSA-168249 | 3.17 |
MAP kinase activation in TLR cascade | R-HSA-450294 | 7.28 |
MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
Activation of NMDA receptor upon glutamate binding and postsynaptic events | R-HSA-442755 | 7.7 |
Activated TLR4 signalling | R-HSA-166054 | 6.27 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
Axon guidance | R-HSA-422475 | 3.93 |
Signal Transduction | R-HSA-162582 | 1.78 |
Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
GO term | GO ID | GO IC |
---|---|---|
endopeptidase inhibitor activity | GO:0004866 | 4.6 |
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
enzyme binding | GO:0019899 | 2.27 |
binding | GO:0005488 | 0.18 |
enzyme inhibitor activity | GO:0004857 | 3.78 |
molecular function regulator | GO:0098772 | 2.51 |
heterocyclic compound binding | GO:1901363 | 1.06 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
nucleoside binding | GO:0001882 | 2.21 |
cation binding | GO:0043169 | 1.4 |
kinase binding | GO:0019900 | 3.32 |
cysteine-type endopeptidase regulator activity involved in apoptotic process | GO:0043028 | 6.02 |
magnesium ion binding | GO:0000287 | 4.41 |
ribonucleoside binding | GO:0032549 | 2.22 |
ion binding | GO:0043167 | 1.36 |
protein serine/threonine kinase activity | GO:0004674 | 3.64 |
transferase activity | GO:0016740 | 1.95 |
purine nucleoside binding | GO:0001883 | 2.22 |
protein kinase activity | GO:0004672 | 3.27 |
purine nucleotide binding | GO:0017076 | 2.19 |
metal ion binding | GO:0046872 | 1.41 |
endopeptidase regulator activity | GO:0061135 | 4.57 |
ATP binding | GO:0005524 | 2.43 |
kinase activity | GO:0016301 | 2.93 |
nucleotide binding | GO:0000166 | 1.96 |
enzyme regulator activity | GO:0030234 | 2.85 |
peptidase regulator activity | GO:0061134 | 4.37 |
small molecule binding | GO:0036094 | 1.89 |
catalytic activity | GO:0003824 | 1.05 |
peptidase inhibitor activity | GO:0030414 | 4.55 |
cysteine-type endopeptidase inhibitor activity | GO:0004869 | 5.71 |
protein kinase binding | GO:0019901 | 3.44 |
adenyl nucleotide binding | GO:0030554 | 2.4 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
adenyl ribonucleotide binding | GO:0032559 | 2.41 |
cysteine-type endopeptidase inhibitor activity involved in apoptotic process | GO:0043027 | 6.6 |
protein binding | GO:0005515 | 0.46 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |